Status:
COMPLETED
DaVinci Registry(Distinctly Assess Vision in Coronary Intervention)
Lead Sponsor:
Abbott Medical Devices
Conditions:
Coronary Disease
Eligibility:
All Genders
18+ years
Brief Summary
Prospective Internet-Registry, Postmarketing-Surveillance, Registration and Follow-up of patients after Multi-Link VISION™ - Stent Implantation
Detailed Description
A Non-Randomized prospective evaluation of the Multi-Link Rx Vision TM Coronary Stent System in the treatment of patients with De novo native coronary artery lesions
Eligibility Criteria
Inclusion
- Women and Men Age \>18 years, Intention to treat all stenosis with Multi-Link VisionTM Stents, documented patient consent
Exclusion
- No Multi-Link Vision™ Stent implanted, life expectation \>9 M, cardiogenic shock, STEMI, NSTEMI or unstable angina pectoris with pathologic markers within the last 48 hours, intolerance of Clopidogrel/ Tiklopidin
Key Trial Info
Start Date :
July 1 2003
Trial Type :
OBSERVATIONAL
End Date :
March 1 2005
Estimated Enrollment :
1300 Patients enrolled
Trial Details
Trial ID
NCT00243438
Start Date
July 1 2003
End Date
March 1 2005
Last Update
January 28 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kerckhoff-Klinik
Bad Nauheim, Germany, 61231